tiprankstipranks
TipRanksTop Financial ExpertsInsidersMatthew Pauls

Matthew Pauls Insider Profile

11 Followers
Matthew Pauls, President & CEO, Director at Strongbridge Biopharma, holds 0.00 shares in Soleno Therapeutics (Ticker: SLNO), holds 15.15K shares in Pelthos Therapeutics (Ticker: PTHS), holds 1.19M shares in Savara (Ticker: SVRA).
See the Hottest Stocks Based on Insider Trading >
tipranks
Matthew Pauls

Matthew Pauls
Strongbridge Biopharma (SBBP)
President & CEO, Director

Ranked #14,485 out of 107,686 Corporate Insiders

Profitable Transactions

75%
6 out of 8 Profitable Transactions

Average Return

+16.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$7M
93.90%
6.10%
0.00%
A breakdown of Matthew Pauls's holdings
See the Top Stocks by Insiders

Insider Roles

Savara
(SVRA)
CEO, Director
Pelthos Therapeutics
(PTHS)
Director
Insmed
(INSM)
CCO
Roles that Matthew Pauls holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Savara
(SVRA)
Rating:Informative Buy
Date:Dec 08, 2021 - Dec 08, 2022
Return:+53.30%
The most profitable trade made by Matthew Pauls
See the Latest Stocks Traded by Insiders

Matthew Pauls's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SBBP
Strongbridge Biopharma
Feb 22, 2019
―
Uninformative Buy
―
$145.22K
SVRA
Savara
Dec 16, 2025
CEO, Director
Uninformative Sell
1.35M
$6.18M
ZCOR
Zyla Life Sciences
May 21, 2020
―
Uninformative Sell
―
$0.00
SLNO
Soleno Therapeutics
May 18, 2026
―
Uninformative Sell
―
$0.00
PTHS
Pelthos Therapeutics
Apr 06, 2026
Director
Uninformative Sell
16.44K
$401.02K
INSM
Insmed
―
CCO
―
$0.00
List of latest transactions for each holding click on a transaction to see Matthew Pauls's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Matthew Pauls insider profile FAQ

What is the percentage of profitable transactions made by Matthew Pauls?
The percentage of profitable transactions made by Matthew Pauls is 75%.
    What is the average return per transaction made by Matthew Pauls?
    The average return per transaction made by Matthew Pauls is 16.50%.
      What stocks does Matthew Pauls hold?
      Matthew Pauls holds: SBBP, SVRA, ZCOR, SLNO, PTHS, INSM stocks.
        What was Matthew Pauls’s latest transaction?
        Matthew Pauls latest transaction was an Uninformative Sell of ―.
          What was Matthew Pauls's most profitable transaction?
          Matthew Pauls’s most profitable transaction was an Informative Buy of SVRA stock on December 8, 2021. The return on the trade was 53.30%.
            What is Matthew Pauls's role in Strongbridge Biopharma?
            Matthew Pauls's role in Strongbridge Biopharma is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.